Akhil Bhalla

Director @Denali Therapeutics

San Francisco, CA, US

EMAILS

[email protected]

MOBILE NUMBERS

+16•••••••73

Reveal Contact Details

Signup · Get unlimited contacts

WORK HISTORY

Sep 2024 — Present

Director @Denali Therapeutics

View department →

South San Francisco, CA, US

Lead biomarker strategy and implementation for IND-E to clinical stage programs. Experienced in Biomarker-based accelerated approval strategy.

EDUCATION

1996 — 2000

The College of Wooster

Bachelor of Arts (BA), Biology, General

2000 — 2006

University of Wisconsin-Madison

Ph.D., Molecular and Cellular Pharmacology

SKILLS

Flow CytometryMolecular CloningBiochemistryIn VitroRt-PcrFluorescenceMolecular ImagingPharmacologyCell CultureLentiviral TechnologyCell BiologyPurificationProtein ExpressionLive-Cell ImagingImmunohistochemistryQpcrHigh Throughput ScreeningProtein ChemistryDrug DiscoveryMolecular BiologyFluorescence MicroscopyBiotechnologyConfocal MicroscopyPharmaceutical IndustryCell Based AssaysNeuroscienceAssay Development

ABOUT AKHIL BHALLA

Collaborative and results-oriented Translational Medicine lead, with a focus on Clinical Biomarkers. Experienced in Biomarkers-based approval strategy. Over 20 years in neuroscience based research including 15 years of industry experience working in multidisciplinary teams. Scientific ExpertiseTranslational Biomarker research in neurodegenerative diseases. Small and large molecule drug development. Therapeutics Areas: Neurodegenerative diseases, various protein misfolding diseases, Lysosomal Storage Disorders.

This profile is compiled from publicly available professional sources. Unifers is not affiliated with or endorsed by LinkedIn. Request removal of this profile.